Vaxcyte (PCVX) Current Assets (2019 - 2026)
Vaxcyte (PCVX) posted Current Assets of $1.55 billion for Q2 2026, down 9.5% from $1.72 billion a year earlier and down 14.4% from the prior quarter.
Powered by 
Analysis
Vaxcyte (PCVX) Current Assets (2019 - 2026) Analysis & Trends
At the end of FY2025, Vaxcyte's Current Assets came in at $1.63 billion, down 9.0% from FY2024.
- Annual Current Assets shows a five-year compound annual growth rate of 33.1% (FY2020 to FY2025).
- In prior years, Vaxcyte's Current Assets was $1.79 billion in FY2024 (+63.1%), $1.1 billion in FY2023 (+16.3%), $942.56 million in FY2022 (+267.7%) and $256.35 million in FY2021 (-34.1%).
- The Q2 2026 figure stands as the lowest quarterly Current Assets since Q2 2024.
- On a year-over-year basis, Current Assets increased in five of the last eight quarters, with growth averaging 16.2%.
- The strongest year-over-year quarter for Current Assets in the past five years was Q4 2022, with growth of 267.7%; the weakest was Q4 2021, with a decline of 34.1%.
- According to Business Quant data, Current Assets for the three prior quarters was $1.81 billion (Q1 2026), $1.63 billion (Q4 2025) and $1.77 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 12.54 Bn |
| 10 | Vaxcyte | 8.44 Bn | 8.44 Bn | - | 1.55 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.55 Bn |
| Mar 31, 2026 | 1.81 Bn |
| Dec 31, 2025 | 1.63 Bn |
| Sep 30, 2025 | 1.77 Bn |
| Jun 30, 2025 | 1.72 Bn |
| Mar 31, 2025 | 1.72 Bn |
| Dec 31, 2024 | 1.79 Bn |
| Sep 30, 2024 | 2.21 Bn |
| Jun 30, 2024 | 1.48 Bn |
| Mar 31, 2024 | 1.52 Bn |
| Dec 31, 2023 | 1.10 Bn |
| Sep 30, 2023 | 1.30 Bn |
| Jun 30, 2023 | 1.31 Bn |
| Mar 31, 2023 | 840.67 Mn |
| Dec 31, 2022 | 942.56 Mn |
| Sep 30, 2022 | 369.76 Mn |
| Jun 30, 2022 | 363.73 Mn |
| Mar 31, 2022 | 342.22 Mn |
| Dec 31, 2021 | 256.35 Mn |
| Sep 30, 2021 | 302.95 Mn |
API Access
Vaxcyte Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=PCVX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "PCVX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=PCVX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();